January 29, 2013 
In the Exchange Traded Market, firms often use software like GMI or Rolfe & Nolan to replicate and reconcile the amount of IM a CCP calls for. In the OTC market this means having your own tools to run a Historic VaR, or similar IM model. My own opinion is that sooner or later users of CCPs for OTC products are going to want the ability to be sure the IM call is “correct”, rather than blindly accept the CCP figures, as the amounts of IM are going to be very large, relative to ETD products.
Please vote below, and I will reveal a summary of the results in a week or so.
Amir Khwaja
Ben Larah
Michael Beaton
corinaki24
Jon Skinner
Mihir Vaidya
Maria Leontiou
samihodgson
Bill Hodgson
Tom Riesack
Bill, while I did not vote as the survey is not intended for strategic consultancies, I can say that I am seeing demand for verifying the CCP calculations, particularly from hedge funds. I just finished a sub-advising engagement where this subject was central to product development initiatives for a large custody bank providing alternative fund administration services. Quite timely.
Best, Mike
In 2014
You can add that in the “Other” box if you like, but thanks for the reply. Bill
Bill, overseeing the buy-side market in DACH, we have seen some clients having an interest in verifying the IM requirements, but as of now most clients have decided to address this challenge after they have solved the clearing and trade repository requirements. From my point of view this will be late 2014 or rather 2015.
Carsten
Thanks for that, I hadn’t come across DACH before, it’s here: http://en.wikipedia.org/wiki/German_language_in_Europe.